Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Nepal Health Res Counc ; 19(2): 408-410, 2021 Sep 06.
Article in English | MEDLINE | ID: covidwho-1449552

ABSTRACT

Violence against health workers has been considered a common issue throughout the world. The protection of health workers in low and middle-income countries such as Nepal has not been considered a serious issue by the government. But due to the surge of COVID-19 pandemic and increasing violence against health workers, commendable steps have been taken by the Government of Nepal to protect the safety and security of health workers and health institutions in Nepal. However, the question mark on effective implementation of the ordinance exits suggesting for the appropriate action from concerned authorities and strong collaboration among these sectors. Keywords: Health worker; Nepal; ordinance; safety.


Subject(s)
COVID-19 , Pandemics , Health Personnel , Humans , Nepal , SARS-CoV-2
2.
J Nepal Health Res Counc ; 18(4): 807-809, 2021 Jan 22.
Article in English | MEDLINE | ID: covidwho-1055439

ABSTRACT

In the race for a safe and effective vaccine against Coronavirus disease-19 manufacturer plays a critical role throughout the development, clinical trial, manufacturing, supply, and vaccination phases. For the efficacy of Coronavirus disease-19 vaccine, proper transport, storage, vaccine carrier, adjuvant, dosage form and route of vaccine administration plays a crucial role for immune response. In the context of no more people were willing to pay for a Coronavirus disease-19 vaccine the logistics of manufacturing, storing and distributing the vaccine, and mass vaccination are essential. It is urgent to improve health promotion and reduce the barriers to Coronavirus disease-19 vaccination. Keywords: COVID-19; vaccine development; vaccination.


Subject(s)
COVID-19 Vaccines/supply & distribution , COVID-19/epidemiology , COVID-19/prevention & control , Drug Industry/organization & administration , Clinical Trials as Topic/organization & administration , Drug Development/organization & administration , Humans , Mass Vaccination/organization & administration , Nepal/epidemiology , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL